Scientists at MIT have announced that they developed novel nanoparticles to detect cancer in urine samples. As well as detecting the presence of tumors, the nanoparticles can also accumulate at tumor sites and function as an imaging agent, helping to identify their location. These multifunctional particles could be very useful for routine cancer screening and… Read More »
FDA Approves Pylarify (piflufolastat F 18) PSMA-Targeted PET Imaging Drug for Men with Prostate Cancer May 27, 2021 — FDA has approved Pylarify (piflufolastat F 18) – a drug for positron emission tomography (PET) imaging of prostate-specific membrane antigen (PSMA) positive lesions in men with prostate cancer. With the approval of Pylarify, certain men with prostate… Read More »
Radiologists say they are “very concerned” patients may not be cured of serious illnesses when demand for services increases, due to a lack of imaging equipment in the UK. The president of the Royal College of Radiologists has warned the service had been “woefully underfunded”. She said cleaning requirements because of coronavirus would reduce capacity.… Read More »
WEST LAFAYETTE, Ind. – A new tool for medical professionals may help shed more light on tumors in the body and how the brain operates. Purdue University researchers created technology that uses optical imaging to better help surgeons map out tumors in the body and help them understand how certain diseases affect activity in the brain.… Read More »
Buried in the federal regulations describing Medicare’s Appropriate Use Criteria Program, which launches January 1, is a pertinent detail: The immediate financial burden of noncompliance with Medicare’s diagnostic imaging requirements will fall squarely on providers that furnish these tests. Yes, that means radiology practices and hospital radiology departments, and not ordering providers. For now, 2020… Read More »